相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Nicole E. Scharping et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma
Sun Hye Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit
Henri Montaudie et al.
PIGMENT CELL & MELANOMA RESEARCH (2017)
Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma
Jarrett J. Failing et al.
MELANOMA RESEARCH (2016)
Combining BRAFV600E inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma
Elisabeth Livingstone et al.
EXPERIMENTAL DERMATOLOGY (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies
Douglas B. Johnson et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Is it time to test biguanide metformin in the treatment of melanoma?
Michael Cerezo et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Optimal therapy of type 2 diabetes: a controversial challenge
Angela Dardano et al.
AGING-US (2014)
Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
Michael Cerezo et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Monica Franciosi et al.
PLOS ONE (2013)
Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
Chang W. Song et al.
SCIENTIFIC REPORTS (2012)
Epithelial-mesenchymal transition in the skin
Motonobu Nakamura et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
Mechanisms of Resistance to RAF Inhibitors in Melanoma
Andrew E. Aplin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
T. Tomic et al.
CELL DEATH & DISEASE (2011)
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
Carolyn Algire et al.
ENDOCRINE-RELATED CANCER (2010)
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
Issam Ben Sahra et al.
MOLECULAR CANCER THERAPEUTICS (2010)
New response evaluation criteria in solid tumors: revised RECIST guideline version 1.1
E. Eisenhauer et al.
EJC SUPPLEMENTS (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways
LGD Fryer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Prognostic factors in invasive cutaneous malignant melanoma:: a population-based study and review
A Måsbäck et al.
MELANOMA RESEARCH (2001)
Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
CM Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle
J Mu et al.
MOLECULAR CELL (2001)